Implanting AVL200 lens to improve vision in cataract patients
A Prospective, Open-label, Single-center Study of the Atia™ AVL200 Modular Intraocular Lens System for Treatment of Cataract and Presbyopia
This study is testing a new lens for cataract surgery to see if it can help patients see better after their operation.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 40 Years and up |
| Sex | All |
| Sponsor | Atia Vision Industry-sponsored |
| Locations | 1 site (Chennai, Tamal Nadu) |
| Trial ID | NCT05627700 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of the AVL200 intraocular lens (IOL) in enhancing visual function for patients undergoing cataract surgery. Eligible participants will receive the AVL200 IOL and will be monitored for one year post-surgery to assess improvements in vision across various focal points. The study aims to determine both the safety and visual outcomes associated with this new lens technology.
Who should consider this trial
Good fit: Ideal candidates include individuals with visually significant cataracts and specific visual acuity requirements.
Not a fit: Patients with certain ocular pathologies or previous corneal surgeries may not benefit from this study.
Why it matters
Potential benefit: If successful, this could lead to improved vision quality for patients suffering from cataracts and presbyopia.
How similar studies have performed: While this approach is innovative, similar studies have shown promise in improving visual outcomes with new IOL technologies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Visually significant cataract * Best corrected distance visual acuity between 20/40 and 20/200 * Potential distance visual acuity of 20/32 or better * Corneal astigmatism ≤ 1.5 diopters Exclusion Criteria: * Use of medication that could affect accommodation * Previous corneal surgery or significant corneal abnormalities * Ocular pathology or degenerative disorder having potential to impair visual acuity * Pupil abnormality * Intraoperative cataract surgery complications that could affect IOL implantation or positioning
Where this trial is running
Chennai, Tamal Nadu
- Dr Agarwal's Eye Hospital — Chennai, Tamal Nadu, India (Recruiting)
Study contacts
- Principal investigator: Ashvin Agarwal, MD — Dr. Agarwals Eye Hospital
- Study coordinator: Melissa Guerrero
- Email: melissa@atiavision.com
- Phone: 408-560-3339
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.